| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...734283J |
| P356 | DOI | 10.1371/JOURNAL.PONE.0034283 |
| P932 | PMC publication ID | 3315582 |
| P698 | PubMed publication ID | 22479587 |
| P5875 | ResearchGate publication ID | 223961215 |
| P2093 | author name string | Daniel Sliva | |
| George E Sandusky | |||
| Jiahua Jiang | |||
| Viktor Krchňák | |||
| Andrej Jedinak | |||
| Anita Thyagarajan-Sahu | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling | Q24650953 | ||
| Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors | Q27620516 | ||
| Aspirin inhibits highly invasive prostate cancer cells | Q28165593 | ||
| Emerging roles for cysteine proteases in human biology | Q28306260 | ||
| Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations | Q29544430 | ||
| Angiogenesis in cancer, vascular, rheumatoid and other disease | Q29547165 | ||
| Synthesis and screening of N-alkyl hydroxamates for inhibition of cancer cell proliferation | Q33263407 | ||
| uPAR: a versatile signalling orchestrator | Q34162183 | ||
| Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells | Q34405107 | ||
| Mechanisms of tumour invasion and metastasis: emerging targets for therapy | Q34837655 | ||
| Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells | Q35220266 | ||
| The selective estrogen enzyme modulators in breast cancer: a review | Q35789599 | ||
| The design and synthesis of aryl hydroxamic acid inhibitors of MMPs and TACE. | Q35867153 | ||
| CDC20, a potential cancer therapeutic target, is negatively regulated by p53. | Q55467766 | ||
| Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits | Q73589806 | ||
| Alphav integrins mediate adhesion and migration of breast carcinoma cell lines | Q74313522 | ||
| Selective, orally active MMP inhibitors with an aryl backbone | Q74493695 | ||
| Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells | Q78454290 | ||
| Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling | Q80872378 | ||
| Molecular signaling regulating anchorage-independent growth of cancer cells. | Q35981149 | ||
| Anaphase-promoting complex-dependent proteolysis of cell cycle regulators and genomic instability of cancer cells | Q36002265 | ||
| The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors | Q36368334 | ||
| Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells | Q38332696 | ||
| Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA. | Q39451627 | ||
| Saxatilin suppresses tumor-induced angiogenesis by regulating VEGF expression in NCI-H460 human lung cancer cells | Q40121204 | ||
| Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer | Q40149269 | ||
| Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells | Q40379734 | ||
| The amyloid precursor protein (APP) and the angiotensin converting enzyme (ACE) secretase are inhibited by hydroxamic acid-based inhibitors | Q41003929 | ||
| The urokinase-type plasminogen activator system in cancer metastasis: A review | Q41522331 | ||
| The biochemistry of cancer dissemination | Q41547351 | ||
| Matrix metalloproteinases. Novel targets for directed cancer therapy | Q41597461 | ||
| Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating succinyl hydroxamate and iminodiacetic acid hydroxamate moieties | Q44594645 | ||
| Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells | Q46642561 | ||
| Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. | Q53639627 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis | Q539568 |
| P304 | page(s) | e34283 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | NAHA, a novel hydroxamic acid-derivative, inhibits growth and angiogenesis of breast cancer in vitro and in vivo | |
| P478 | volume | 7 |
| Q34540424 | A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells. |
| Q33750165 | Cdc20 and securin overexpression predict short-term breast cancer survival. |
| Q33584460 | Cdc20: a potential novel therapeutic target for cancer treatment |
| Q49584310 | Cell division cycle 20 promotes cell proliferation and invasion and inhibits apoptosis in osteosarcoma cells |
| Q47636038 | E3 ubiquitin ligases in cancer and implications for therapies |
| Q89909200 | Integrative module analysis of HCC gene expression landscapes |
| Q36881446 | Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. |
| Q37688442 | Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cells |
| Q35688708 | Targeting Cdc20 as a novel cancer therapeutic strategy |
| Q26866185 | Targeting the ubiquitin pathway for cancer treatment |
| Q92023091 | The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma |
| Q36221605 | The effects of a novel aliphatic-chain hydroxamate derivative WMJ-S-001 in HCT116 colorectal cancer cell death |
| Q37307247 | The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy |
| Q34374287 | USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma |
| Q48227330 | WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via the SHP-1-STAT3-survivin cascade |
| Q35238403 | WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-angiogenic activities via Src-homology-2-domain-containing protein tyrosine phosphatase 1 |
| Q38927398 | WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-inflammatory properties via MKP-1 in LPS-stimulated RAW264.7 macrophages |
Search more.